Corrigendum to “Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway” [Biomed. Pharmacother. 115 (2019) 108922]
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-05-01
|
| Series: | Biomedicine & Pharmacotherapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222002542 |
| _version_ | 1811299717705891840 |
|---|---|
| author | Xiaohong Xu Vinothakumar Rajamanicham Sujing Xu Zhoudi Liu Tao Yan Guang Liang Guilong Guo Huiping Zhou Yi Wang |
| author_facet | Xiaohong Xu Vinothakumar Rajamanicham Sujing Xu Zhoudi Liu Tao Yan Guang Liang Guilong Guo Huiping Zhou Yi Wang |
| author_sort | Xiaohong Xu |
| collection | DOAJ |
| first_indexed | 2024-04-13T06:39:56Z |
| format | Article |
| id | doaj.art-240da20639bc4d12a2c8d20d431f2d20 |
| institution | Directory Open Access Journal |
| issn | 0753-3322 |
| language | English |
| last_indexed | 2024-04-13T06:39:56Z |
| publishDate | 2022-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Biomedicine & Pharmacotherapy |
| spelling | doaj.art-240da20639bc4d12a2c8d20d431f2d202022-12-22T02:57:46ZengElsevierBiomedicine & Pharmacotherapy0753-33222022-05-01149112865Corrigendum to “Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway” [Biomed. Pharmacother. 115 (2019) 108922]Xiaohong Xu0Vinothakumar Rajamanicham1Sujing Xu2Zhoudi Liu3Tao Yan4Guang Liang5Guilong Guo6Huiping Zhou7Yi Wang8Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR ChinaChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR ChinaChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR ChinaChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR ChinaChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR ChinaChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR ChinaDepartment of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, PR ChinaChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR ChinaChemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR China; Corresponding author.http://www.sciencedirect.com/science/article/pii/S0753332222002542 |
| spellingShingle | Xiaohong Xu Vinothakumar Rajamanicham Sujing Xu Zhoudi Liu Tao Yan Guang Liang Guilong Guo Huiping Zhou Yi Wang Corrigendum to “Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway” [Biomed. Pharmacother. 115 (2019) 108922] Biomedicine & Pharmacotherapy |
| title | Corrigendum to “Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway” [Biomed. Pharmacother. 115 (2019) 108922] |
| title_full | Corrigendum to “Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway” [Biomed. Pharmacother. 115 (2019) 108922] |
| title_fullStr | Corrigendum to “Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway” [Biomed. Pharmacother. 115 (2019) 108922] |
| title_full_unstemmed | Corrigendum to “Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway” [Biomed. Pharmacother. 115 (2019) 108922] |
| title_short | Corrigendum to “Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway” [Biomed. Pharmacother. 115 (2019) 108922] |
| title_sort | corrigendum to schisandrin a inhibits triple negative breast cancer cells by regulating wnt er stress signaling pathway biomed pharmacother 115 2019 108922 |
| url | http://www.sciencedirect.com/science/article/pii/S0753332222002542 |
| work_keys_str_mv | AT xiaohongxu corrigendumtoschisandrinainhibitstriplenegativebreastcancercellsbyregulatingwnterstresssignalingpathwaybiomedpharmacother1152019108922 AT vinothakumarrajamanicham corrigendumtoschisandrinainhibitstriplenegativebreastcancercellsbyregulatingwnterstresssignalingpathwaybiomedpharmacother1152019108922 AT sujingxu corrigendumtoschisandrinainhibitstriplenegativebreastcancercellsbyregulatingwnterstresssignalingpathwaybiomedpharmacother1152019108922 AT zhoudiliu corrigendumtoschisandrinainhibitstriplenegativebreastcancercellsbyregulatingwnterstresssignalingpathwaybiomedpharmacother1152019108922 AT taoyan corrigendumtoschisandrinainhibitstriplenegativebreastcancercellsbyregulatingwnterstresssignalingpathwaybiomedpharmacother1152019108922 AT guangliang corrigendumtoschisandrinainhibitstriplenegativebreastcancercellsbyregulatingwnterstresssignalingpathwaybiomedpharmacother1152019108922 AT guilongguo corrigendumtoschisandrinainhibitstriplenegativebreastcancercellsbyregulatingwnterstresssignalingpathwaybiomedpharmacother1152019108922 AT huipingzhou corrigendumtoschisandrinainhibitstriplenegativebreastcancercellsbyregulatingwnterstresssignalingpathwaybiomedpharmacother1152019108922 AT yiwang corrigendumtoschisandrinainhibitstriplenegativebreastcancercellsbyregulatingwnterstresssignalingpathwaybiomedpharmacother1152019108922 |